Skip to main content
SpringerLink
Log in

Karzinom des Magens

  • Chapter
  • First Online:
Pathologie

Part of the book series: Pathologie ((PATHOL))

  • 6383 Accesses

Zusammenfassung

In diesem Kapitel werden alle malignen epithelialen Tumoren des Magens mit den derzeit aktuellen Definitionen und histopathologischen Diagnosekriterien detailliert in Wort und Bild dargestellt und durch die aktuellen Daten zur Molekularpathologie, Inzidenz und Ätiologie sowie zur Therapie ergänzt. Besondere Berücksichtigung finden die histologischen Kriterien der unterschiedlichen Subtypen, der Graduierungssysteme sowie der international und national gebräuchlichsten Klassifikationen. Im Abschnitt „Differentialdiagnose“ werden alle häufigen, aber auch die seltenen Entitäten diskutiert und Kriterien zur Abgrenzung genannt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 359.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Becker K, Mueller J, Fink U, Busch R, Siewert JR, Hofler H (2000) Morphologic response evaluation of neoadjuvant chemotherapy of gastric carcinoma. Verh Dtsch Ges Pathol 84:164–174

    CAS  PubMed  Google Scholar 

  2. Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, Bottcher K, Siewert JR, Hofler H (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98:1521–1530

    Article  PubMed  Google Scholar 

  3. Borrmann R (1926) Geschwülste des Magens. In: Henke F, Lubarsch O (Hrsg) Handbuch der speziellen pathologischen Anatomie und Histologie. Bd IV/1. Springer, Berlin

    Google Scholar 

  4. Bosman F, Carneiro F, Hruban R, Theise N (2010) WHO Classification of Tumours of the digestive systems. IARC Press, Lyon

    Google Scholar 

  5. Brennetot C, Duval A, Hamelin R, Pinto M, Oliveira C, Seruca R, Schwartz Jr S (2003) Frequent Ki-ras mutations in gastric tumors of the MSI phenotype. Gastroenterology 125:1282

    Article  PubMed  Google Scholar 

  6. Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK, Lutzke LS (2002) The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst 94:422–429

    Article  CAS  PubMed  Google Scholar 

  7. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ (2002) Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 122:1101–1112

    Article  CAS  PubMed  Google Scholar 

  8. Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ (2001) Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120:1630–1639

    Article  CAS  PubMed  Google Scholar 

  9. Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simoes M (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203:681–687

    Article  CAS  PubMed  Google Scholar 

  10. Carneiro F, Seixas M, Sobrinho-Simoes M (1995) New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191:571–584

    Article  CAS  PubMed  Google Scholar 

  11. Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG (2004) Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 53:814–820

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Clark GW (2003) Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma. World J Surg 27:994–998

    Article  PubMed  Google Scholar 

  13. Correa P (1988) A human model of gastric carcinogenesis. Cancer Res 48:3554–3560

    CAS  PubMed  Google Scholar 

  14. Correa P (2003) Bacterial infections as a cause of cancer. J Natl Cancer Inst 95:E3

    Article  PubMed  Google Scholar 

  15. Corredor J, Wambach J, Barnard J (2001) Gastrointestinal polyps in children: advances in molecular genetics, diagnosis, and management. J Pediatr 138:621–628

    Article  CAS  PubMed  Google Scholar 

  16. Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek Jr. RM (2003) Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology 125:1125–1136

    Article  CAS  PubMed  Google Scholar 

  17. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ebert MP, Malfertheiner P (2002) Review article: Pathogenesis of sporadic and familial gastric cancer – implications for clinical management and cancer prevention. Aliment Pharmacol Ther 16:1059–1066

    Article  PubMed  Google Scholar 

  19. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni Jr. JF, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402

    Article  CAS  PubMed  Google Scholar 

  20. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni Jr. JF, Chow WH (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124:1193–1201

    Article  CAS  PubMed  Google Scholar 

  21. El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY (2001) Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 54:679–683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni Jr. JF (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404–1413

    Article  PubMed  Google Scholar 

  23. Faller G, Berndt R, Borchard F, Ell C, Fuchs KH, Geddert H, Gossner L, Gunther T, Kirchner T, Koch HK, Langner C, Luttges J, May A, Muller S, Oberhuber G, Seitz G, Stolte M, Tannapfel A, Vieth M, Walch A, Ruschoff J (2003) Histopathological diagnosis of Barrett's mucosa and associated neoplasias. Results of a consensus conference of the Working Group for "Gastroenterological Pathology of the German Society for Pathology" on 22 September 2001. Pathologe 24:9–14

    CAS  PubMed  Google Scholar 

  24. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Listrom MB, Rilke FO (1999) Gastrointestinal pathology. An atlas and text. Lippincott-Raven, Philadelphia

    Google Scholar 

  25. Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A (2003) TP53 and gastric carcinoma: a review. Hum Mutat 21:258–270

    Article  CAS  PubMed  Google Scholar 

  26. Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, Teuchmann S, Benz M, Prijon T (1994) Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 57:324–329

    Article  CAS  PubMed  Google Scholar 

  27. Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, Schatzkin A (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165:1424–1433

    Article  PubMed  Google Scholar 

  28. Fritz A, Percy C, Jack A et al (2000) International classification of diseases for oncology (ICD-O). WHO, Geneva

    Google Scholar 

  29. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333:32–41

    Article  CAS  PubMed  Google Scholar 

  30. Fujino Y, Tamakoshi A, Ohno Y, Mizoue T, Tokui N, Yoshimura T (2002) Prospective study of educational background and stomach cancer in Japan. Prev Med 35:121–127

    Article  PubMed  Google Scholar 

  31. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA, Caldas C (1998) Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58:4086–4089

    CAS  PubMed  Google Scholar 

  32. Gibbons AH (2003) Helicobacter pylori: a clinician's view. Hosp Med 64:535–538

    Article  CAS  PubMed  Google Scholar 

  33. Goseki N, Takizawa T, Koike M (1992) Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 33:606–612

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405

    Article  CAS  PubMed  Google Scholar 

  35. Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MP, Reeve AE (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14:249–255

    Article  CAS  PubMed  Google Scholar 

  36. Gylling A, Abdel-Rahman WM, Juhola M, Nuorva K, Hautala E, Jarvinen HJ, Mecklin JP, Aarnio M, Peltomaki P (2007) Is gastric cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? A molecular genetic study. Gut 56:926–933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hamilton S, Aaltonen L (2000) Pathology and genetics; tumours of the digestive system. IARC Press, Lyon

    Google Scholar 

  38. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni Jr. JF, Adami HO (1996) The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335:242–249

    Article  CAS  PubMed  Google Scholar 

  39. Hermanek P, Maruyama K, Sobin LH et al (1995) Stomach carcinoma. In: Hermanek P (Hrsg) Prognostic factors in cancer. Springer, Berlin, S 47–63

    Chapter  Google Scholar 

  40. Hermanek P, Wittekind C (1993) Histological typing and grading of gastric carcinoma. In: Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E (Hrsg) Gastric cancer. Springer, Berlin

    Google Scholar 

  41. Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER (2002) CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123:1565–1577

    Article  CAS  PubMed  Google Scholar 

  42. Hirata T, Yamamoto H, Taniguchi H, Horiuchi S, Oki M, Adachi Y, Imai K, Shinomura Y (2007) Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability. J Pathol 211:516–523

    Article  CAS  PubMed  Google Scholar 

  43. Hofler H, Becker KF (2003) Molecular mechanisms of carcinogenesis in gastric cancer. Recent Results Cancer Res 162:65–72

    Article  PubMed  Google Scholar 

  44. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362:305–315

    Article  PubMed  Google Scholar 

  45. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M (1998) Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 58:4255–4259

    CAS  PubMed  Google Scholar 

  46. Huntsman D, Carneiro F, Lewis F, MacLeod P, Hayashi A, Monaghan K, Maung R, Seruca R, Jackson C, Caldas C (2001) Prophylactic gastrectomy in patients with deleterious E-cadherin gene mutation. Gastroenterol Clin Biol 25:931–932

    CAS  PubMed  Google Scholar 

  47. Ishiguro K, Kawakami K, Maeda K, Ishida Y, Omura K, Watanabe G (2003) Microsatellite instability in gastric cancer is closely associated with hMLH1 hypermethylation at the proximal region of the promoter. Int J Mol Med 12:603–608

    CAS  PubMed  Google Scholar 

  48. Ito H, Tahara E (1983) Human chorionic gonadotropin in human gastric carcinoma. A retrospective immunohistochemical study. Acta Pathol Jpn 33:287–296

    CAS  PubMed  Google Scholar 

  49. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS (2003) Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163:1551–1556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Karlson BM, Ekbom A, Wacholder S, McLaughlin JK, Hsing AW (2000) Cancer of the upper gastrointestinal tract among patients with pernicious anemia: a case-cohort study. Scand J Gastroenterol 35:847–851

    Article  CAS  PubMed  Google Scholar 

  51. Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1–9

    Article  PubMed  Google Scholar 

  52. Kitayama Y, Igarashi H, Watanabe F, Maruyama Y, Kanamori M, Sugimura H (2003) Nonrandom chromosomal numerical abnormality predicting prognosis of gastric cancer: a retrospective study of 51 cases using pathology archives. Lab Invest 83:1311–1320

    Article  PubMed  Google Scholar 

  53. Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T (2007) Expression of mutant type-p53 products in H pylori-associated chronic gastritis. World J Gastroenterol 13:1541–1546

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kodama Y, Inokuchi K, Soejima K, Matsusaka T, Okamura T (1983) Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types. Cancer 51:320–326

    Article  CAS  PubMed  Google Scholar 

  55. Lauren P (1965) The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49

    CAS  PubMed  Google Scholar 

  56. Lauwers GY (2003) Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 36:S37–S43

    Article  PubMed  Google Scholar 

  57. Lauwers GY, Shimizu M, Correa P, Riddell RH, Kato Y, Lewin KJ, Yamabe H, Sheahan DG, Lewin D, Sipponen P, Kubilis PS, Watanabe H (1999) Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists. Am J Surg Pathol 23:511–518

    Article  CAS  PubMed  Google Scholar 

  58. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85

    Article  CAS  PubMed  Google Scholar 

  59. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro AC, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M (2003) A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125:364–371

    Article  CAS  PubMed  Google Scholar 

  60. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki IM, Honjo T, Chiba T (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13:470–476

    Article  CAS  PubMed  Google Scholar 

  61. Matsunou H, Konishi F, Jalal RE, Yamamichi N, Mukawa A (1994) Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation. Cancer 73:534–540

    Article  CAS  PubMed  Google Scholar 

  62. McLaren KM, Burnett RA, Goodlad JR, Howatson SR, Lang S, Lee FD, Lessells AM, Ogston SA, Robertson AJ, Simpson JG, Smith GD, Tavadia HB, Walker F (2003) Observer variability in the Goseki grouping of gastric adenocarcinoma in resection and biopsy specimens. Histopathology 42:472–475

    Article  CAS  PubMed  Google Scholar 

  63. Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M (2001) Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 15:983–998

    Article  CAS  PubMed  Google Scholar 

  64. Meining A, Riedl B, Stolte M (2002) Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol 55:770–773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Mesquita P, Jonckheere N, Almeida R, Ducourouble MP, Serpa J, Silva E, Pigny P, Silva FS, Reis C, Silberg D, Van SI, David L (2003) Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J Biol Chem 278:51549–51556

    Article  CAS  PubMed  Google Scholar 

  66. Mihara M, Yoshida Y, Tsukamoto T, Inada K, Nakanishi Y, Yagi Y, Imai K, Sugimura T, Tatematsu M, Ushijima T (2006) Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins. Am J Pathol 169:1643–1651

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Ming SC (1977) Gastric carcinoma. A pathobiological classification. Cancer 39:2475–2485

    Article  CAS  PubMed  Google Scholar 

  68. Möhler M, Ebert MP, Galle PR (2010) S3-Leitlinie Magenkarzinom: Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs.

    Google Scholar 

  69. Nardone G (2003) Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 17(Suppl 2):75–81

    Article  CAS  PubMed  Google Scholar 

  70. Oliveira C, Seruca R, Caldas C (2003) Genetic screening for hereditary diffuse gastric cancer. Expert Rev Mol Diagn 3:201–215

    Article  CAS  PubMed  Google Scholar 

  71. Park YJ, Shin KH, Park JG (2000) Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 6:2994–2998

    CAS  PubMed  Google Scholar 

  72. Riddell RH, Iwafuchi M (1998) Problems arising from eastern and western classification systems for gastrointestinal dysplasia and carcinoma: are they resolvable? Histopathology 33:197–202

    Article  CAS  PubMed  Google Scholar 

  73. Roder DM (2002) The epidemiology of gastric cancer. Gastric Cancer 5(Suppl 1):5–11

    Article  PubMed  Google Scholar 

  74. Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, Morgagni P, Saragoni L, de Manzoni G, Tomezzoli A (2006) Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 94:275–280

    Article  PubMed  Google Scholar 

  75. Ruschoff J, Dietel M, Baretton G, Arbogast S, Walch A, Monges G, Chenard MP, Penault-Llorca F, Nagelmeier I, Schlake W, Hofler H, Kreipe HH (2010) HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing. Virchows Arch 457:299–307

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Saragoni L, Gaudio M, Morgagni P, Folli S, Vio A, Scarpi E, Saragoni A (2000) The role of growth patterns, according to Kodama's classification, and lymph node status, as important prognostic factors in early gastric cancer: analysis of 412 cases. Gastric Cancer 3:134–140

    Article  PubMed  Google Scholar 

  77. Schandl L, Malfertheiner P, Ebert MP (2002) Prevention of gastric cancer by Helicobacter pylori eradication? Results from clinical intervention studies. Dig Dis 20:18–22

    Article  PubMed  Google Scholar 

  78. Schmitt-Thomas B (2002) Kurzgefasste interdisziplinäre Leitlinien. Zuckschwerdt, München

    Google Scholar 

  79. Sendler A, Siewert JR (2003) Individualizing therapy in gastric cancer. Expert Rev Anticancer Ther 3:457–470

    Article  CAS  PubMed  Google Scholar 

  80. Shaw D, Blair V, Framp A, Harawira P, McLeod M, Guilford P, Parry S, Charlton A, Martin I (2005) Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 54:461–468

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Sipponen P, Correa P (2002) Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5:213–219

    Article  PubMed  Google Scholar 

  82. Sommerer F, Vieth M, Markwarth A, Rohrich K, Vomschloss S, May A, Ell C, Stolte M, Hengge UR, Wittekind C, Tannapfel A (2004) Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma. Oncogene 23:554–558

    Article  CAS  PubMed  Google Scholar 

  83. Songun I, van de Velde CJ, Arends JW, Blok P, Grond AJ, Offerhaus GJ, Hermans J, van Krieken JH (1999) Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer 85:2114–2118

    Article  CAS  PubMed  Google Scholar 

  84. Stein HJ, von Rahden BH, Hofler H, Siewert JR (2003) Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model? Chirurg 74:703–708

    Article  CAS  PubMed  Google Scholar 

  85. Tannapfel A (2001) Current state of molecular pathology of stomach carcinomas. Pathologe 22:37–43

    Article  CAS  PubMed  Google Scholar 

  86. Rüschoff J, Hanna W, Bilous M, Hofmann M, Osamura RY, Penault-Llorca F, van de Vijver M, Viale G (2012) HER2 testing in gastric cancer: a practical approach. Mod Pathol 25:637–650

    Article  PubMed  CAS  Google Scholar 

  87. Tannapfel A, Kuhn R, Kessler H, Wittekind C (1996) Expression of c-erbB2 oncogene product in different tumours and its standardised evaluation. Anal Cell Pathol 10:149–160

    CAS  PubMed  Google Scholar 

  88. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kan YK (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697

    Article  CAS  PubMed  Google Scholar 

  89. Tannapfel A, Schmelzer S, Benicke M, Klimpfinger M, Kohlhaw K, Mossner J, Engeland K, Wittekind C (2001) Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer. J Pathol 195:163–170

    Article  CAS  PubMed  Google Scholar 

  90. Tannapfel A, Wittekind C, Tahara E (1994) Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer. Z Gastroenterol 32:91–93

    CAS  PubMed  Google Scholar 

  91. Tannapfel A, Yasui W, Yokozaki H, Wittekind C, Tahara E (1994) Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines. Virchows Arch 425:139–144

    Article  CAS  PubMed  Google Scholar 

  92. Tatematsu M, Tsukamoto T, Inada K (2003) Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94:135–141

    Article  CAS  PubMed  Google Scholar 

  93. Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, Wang W, Blot WJ, Dong ZW, Mark SD (2003) Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 95:1414–1416

    Article  PubMed  Google Scholar 

  94. Testino G, Cornaggia M (2002) Gastric epithelial dysplasia and gastric cancer in young dyspeptic patients treated with proton pump inhibitors. J Clin Gastroenterol 34:282–283

    Article  PubMed  Google Scholar 

  95. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789

    Article  CAS  PubMed  Google Scholar 

  96. Varis A, van Rees B, Weterman M, Ristimaki A, Offerhaus J, Knuutila S (2003) DNA copy number changes in young gastric cancer patients with special reference to chromosome. Br J Cancer 19(88):1914–1919

    Article  CAS  Google Scholar 

  97. Wainess RM, Dimick JB, Upchurch Jr. GR, Cowan JA, Mulholland MW (2003) Epidemiology of surgically treated gastric cancer in the United States. J Gastrointest Surg 7:87–883

    Google Scholar 

  98. Walker MM (2003) Is intestinal metaplasia of the stomach reversible? Gut 52:1–4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC (2003) Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 95:1784–1791

    Article  CAS  PubMed  Google Scholar 

  100. Watanabe H, Jass J, Sobin L (1990) Histological typing of oesophageal and gastric tumours. In: WHO (Hrsg) International Histological Classification of tumours. Springer, Berlin

    Google Scholar 

  101. Weiss MM, Kuipers EJ, Postma C, Snijders AM, Stolte M, Vieth M, Pinkel D, Meuwissen SG, Albertson D, Meijer GA (2003) Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol Pathol 56:293–298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM Supplement. Wiley & Sons, New York

    Book  Google Scholar 

  103. Wittekind C, Meyer HJ (2010) TNM Klassifikation maligner Tumore. Wiley-Blackwell, Weinheim

    Google Scholar 

  104. Wittekind C, Klimpfinger M, Hermanek P, Tannapfel A (1997) Multiple simultaneous gastric carcinomas. Br J Cancer 76:1604–1609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Wong JE, Ito Y, Correa P, Peeters KC, van de Velde CJ, Sasako M, Macdonald J (2003) Therapeutic strategies in gastric cancer. J Clin Oncol 21: 267 s–269 s

    Google Scholar 

  106. Young LS, Murray PG (2003) Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22:5108–5121

    Article  CAS  PubMed  Google Scholar 

  107. Yuasa Y (2003) Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3:592–600

    Article  CAS  PubMed  Google Scholar 

  108. Zeeb H, Razum O, Blettner M, Stegmaier C (2002) Transition in cancer patterns among Turks residing in Germany. Eur J Cancer 38:705–711

    Article  CAS  PubMed  Google Scholar 

  109. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N (2005) Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol 11:791–796

    Article  PubMed  PubMed Central  Google Scholar 

  110. Zittel TT (2002) Epidemiology, Ätiologie, Diagnostik und Therapie des Magenkarzinoms. Med Welt 53:243–249

    Google Scholar 

Download references

Author information

Author notes

  1. Andrea Tannapfel Prof. Dr. med.

    Present address: Institut für Pathologie, Ruhr-Universität Bochum, Bürkle-de-la-Camp Platz 1, 44789, Bochum, Deutschland

Authors and Affiliations

    Authors
    1. Andrea Tannapfel Prof. Dr. med.
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Andrea Tannapfel Prof. Dr. med. .

    Editor information

    Editors and Affiliations

    1. Institut für Pathologie, Klinikum Kulmbach, Kulmbach, Germany

      Manfred Stolte

    2. Institut für Pathologie Nordhessen, Kassel, Germany

      Josef Rüschoff

    3. Konsultationszentrum für Pankreas- und, Technische Universität München Klinikum rechts der Isar, München, Germany

      Günter Klöppel

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2013 Springer-Verlag Berlin Heidelberg

    About this chapter

    Cite this chapter

    Tannapfel, A. (2013). Karzinom des Magens. In: Stolte, M., Rüschoff, J., Klöppel, G. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02322-4_12

    Download citation

    • DOI: https://doi.org/10.1007/978-3-642-02322-4_12

    • Published:

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-642-02321-7

    • Online ISBN: 978-3-642-02322-4

    • eBook Packages: Medicine (German Language)

    Publish with us

    Policies and ethics

    Search

    Navigation